Literature DB >> 24938368

[Trauma-related secondary glaucoma in childhood: a therapeutic challenge].

A Anton1, M Neuburger, T Wecker, J F Jordan.   

Abstract

CASE REPORT: We performed a minimally invasive trabeculotomy using a trabectome on a 9-year-old boy with a trauma-related secondary glaucoma where the intraocular pressure (IOP) could not be controlled by conservative approaches. After a 1-year follow-up the patient showed well controlled IOP values without using drugs to reduce pressure.
CONCLUSION: Trabectome surgery seems to be a suitable first step intervention for trauma-related glaucoma in selected cases, even in children.

Entities:  

Mesh:

Year:  2014        PMID: 24938368     DOI: 10.1007/s00347-014-3079-z

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  6 in total

1.  Chronic secondary glaucoma. Associated with retrodisplacement of iris root and deepening of the anterior chamber angle secondary to contusion.

Authors:  S M WOLFF; L E ZIMMERMAN
Journal:  Am J Ophthalmol       Date:  1962-10       Impact factor: 5.258

2.  "Cyclodiode". Trans-scleral diode laser cyclophotocoagulation in the treatment of advanced refractory glaucoma.

Authors:  P A Bloom; J C Tsai; K Sharma; M H Miller; N S Rice; R A Hitchings; P T Khaw
Journal:  Ophthalmology       Date:  1997-09       Impact factor: 12.079

3.  Efficacy and safety of contact transscleral diode laser cyclophotocoagulation for advanced glaucoma.

Authors:  T Schlote; M Derse; K Rassmann; T Nicaeus; K Dietz; H J Thiel
Journal:  J Glaucoma       Date:  2001-08       Impact factor: 2.503

Review 4.  [Traumatic glaucoma--a survey].

Authors:  T Schlote; M Rohrbach
Journal:  Klin Monbl Augenheilkd       Date:  2005-10       Impact factor: 0.700

5.  Long-term follow-up of traumatic glaucoma treated with Molteno implants.

Authors:  J R Fuller; T H Bevin; A C Molteno
Journal:  Ophthalmology       Date:  2001-10       Impact factor: 12.079

Review 6.  Management of traumatic hyphema.

Authors:  William Walton; Stanley Von Hagen; Ruben Grigorian; Marco Zarbin
Journal:  Surv Ophthalmol       Date:  2002 Jul-Aug       Impact factor: 6.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.